Cart
sales@molnova.com
Senkyunolide I
CAS No. 94596-28-8
Senkyunolide I( Senkyunolide I | Ligustilidiol, (Z)- | Ligustilidiol )
Catalog No. M19281 CAS No. 94596-28-8
Senkyunolide I has neuroprotective effect, associated with its anti-oxidation and anti-apoptosis properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 76 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 266 | In Stock |
|
| 100MG | 394 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSenkyunolide I
-
NoteResearch use only, not for human use.
-
Brief DescriptionSenkyunolide I has neuroprotective effect, associated with its anti-oxidation and anti-apoptosis properties.
-
DescriptionSenkyunolide I has antioxidant and anti-migraine activities; isolated from Ligusticum chuanxiong.
-
In Vitro——
-
In Vivo——
-
SynonymsSenkyunolide I | Ligustilidiol, (Z)- | Ligustilidiol
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number94596-28-8
-
Formula Weight224.25
-
Molecular FormulaC12H16O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (445.93 mM)
-
SMILESCCCC=C1C2=C(C(C(CC2)O)O)C(=O)O1
-
Chemical Name(6R,7R,Z)-3-butylidene-6,7-dihydroxy-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
3-(2-Glucosyloxy-4-m...
2-O-beta-d-Glucosyloxy-4-methoxybenzenepropanoic acid[3-(2-Glucosyloxy-4-methoxyphenyl)propanoic acid] exhibits glutathione S-transferase (GST) inhibitory and antifungal activities.
-
3-Oxo-C14-AHL
N-(3-Oxotetradecanoyl)-DL-homoserine lactone, part of the N-Acyl homoserine lactone (AHL) family derived from gram-negative bacteria, serves as a quorum sensing (QS) signaling molecule.
-
Tinurilimab
Tinurilimab (Bay 1834942) is a monoclonal antibody that targets and inhibits CEACAM6, an immune checkpoint regulator. Tinurilimab can be used in studies about effector T-cells against tumors.
